Advertisement
Screener

DNA X, Inc. (SONM) Revenue

DNA X, Inc. Revenue

DNA X, Inc. (SONM) reported Revenue of $16.21 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-31.

Financial Statements › Income Statement › Revenue

us-gaap:Revenues · last filed 2025-10-31

  • DNA X, Inc. revenues for the quarter ending 2025-09-30 was $16.21M, a 7.94% increase year-over-year.
  • DNA X, Inc. revenues for the quarter ending 2025-06-30 was $11.19M, a 2.83% decline year-over-year.
  • DNA X, Inc. revenues for the quarter ending 2025-03-31 was $16.72M, a 0.33% decline year-over-year.
  • DNA X, Inc. revenues for the quarter ending 2024-12-31 was $14.98M, a 11.57% increase year-over-year.
  • DNA X, Inc. revenues for fiscal 2024 was $58.30M, a 37.74% decline from fiscal 2023.
  • DNA X, Inc. revenues for fiscal 2023 was $93.63M.
Period endRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 month
2025-09-30$16.21M
10-Q · filed 2025-10-31
$27.40M
derived: sum of 2 quarters · filed 2025-10-31
$44.13M
10-Q · filed 2025-10-31
$59.11M
derived: sum of 4 quarters · filed 2025-10-31
2025-06-30$11.19M
10-Q · filed 2025-08-08
$27.91M
10-Q · filed 2025-08-08
$42.90M
derived: sum of 3 quarters · filed 2025-08-08
$57.92M
derived: sum of 4 quarters · filed 2025-10-31
2025-03-31$16.72M
10-Q · filed 2025-05-12
$31.70M
derived: sum of 2 quarters · filed 2025-05-12
$46.73M
derived: sum of 3 quarters · filed 2025-10-31
$58.24M
derived: sum of 4 quarters · filed 2025-10-31
2024-12-31$14.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$30.01M
derived: sum of 2 quarters · filed 2025-10-31
$41.52M
derived: sum of 3 quarters · filed 2025-10-31
$58.30M
10-K · filed 2025-03-31
2024-09-30$15.02M
10-Q · filed 2025-10-31
$26.54M
derived: sum of 2 quarters · filed 2025-10-31
$43.31M
10-Q · filed 2025-10-31
$56.74M
derived: sum of 4 quarters · filed 2025-10-31
2024-06-30$11.52M
10-Q · filed 2025-08-08
$28.29M
10-Q · filed 2025-08-08
$41.72M
derived: sum of 3 quarters · filed 2025-08-08
$69.29M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$16.78M
10-Q · filed 2025-05-12
$30.21M
derived: sum of 2 quarters · filed 2025-05-12
$57.77M
derived: sum of 3 quarters · filed 2025-05-12
2023-12-31$13.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$41.00M
derived: sum of 2 quarters · filed 2025-03-31
$93.63M
10-K · filed 2025-03-31
2023-09-30$27.57M
10-Q · filed 2024-11-13
$80.20M
10-Q · filed 2024-11-13
2019-09-30$28.85M
10-Q · filed 2019-11-12
$72.60M
derived: sum of 2 quarters · filed 2019-11-12
$99.08M
10-Q · filed 2019-11-12
2019-06-30$43.75M
10-Q · filed 2019-08-13
$70.23M
10-Q · filed 2019-08-13
2019-03-31$26.48M
10-Q · filed 2019-06-24
2018-09-30$39.50M
10-Q · filed 2019-11-12
$70.95M
derived: sum of 2 quarters · filed 2019-11-12
$89.14M
10-Q · filed 2019-11-12
2018-06-30$31.45M
10-Q · filed 2019-08-13
$49.64M
10-Q · filed 2019-08-13
2018-03-31$18.19M
10-Q · filed 2019-06-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
CLEARONE INC (CLRO)United States$0.009B
FRANKLIN WIRELESS CORP (FKWL)United States$0.028B-61.80
FiEE, Inc. (FIEE)Japan$0.033B8.06
Clearfield, Inc. (CLFD)United States$0.415B-74.88
ADTRAN Holdings, Inc. (ADTN)United States$0.565B-43.25
Fabrinet (FN)$14.287B39.79
CIENA CORP (CIEN)United States$50.874B81.72